IP Library Granted Patent US 8,428,748
Granted Patent B2
US 8,428,748 · App. 13/447,050 · Granted Apr 23, 2013

Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,428,748
App. No.
13/447,050
Granted
Apr 23, 2013
Kind
B2
Abstract

Selective high-frequency spinal chord modulation for inhibiting pain with reduced side affects and associated systems and methods are disclosed. In particular embodiments, high-frequency modulation in the range of from about 1.5 KHz to about 50 KHz may be applied to the patient's spinal chord region to address low back pain without creating unwanted sensory and/or motor side affects. In other embodiments, modulation in accordance with similar parameters can be applied to other spinal or peripheral locations to address other indications.

Claims (54)

1. A method for treating a patient, comprising:

delivering or instructing delivery of at least one non-paresthesia-producing electrical signal to the patient's spinal cord via at least one implantable signal delivery device, the signal having a frequency in a frequency range of from about 1.5 kHz to about 50 kHz; and

on a repeated basis, interrupting or instructing interruption of the electrical signal for a period of at least 10 minutes.

2. The method of claim 1 wherein the repeated basis is a cyclic basis.

3. The method of claim 1 wherein the interruption is performed automatically.

4. The method of claim 1 wherein interruption of the electrical signal includes interruption of the electrical signal for a period of up to 20 minutes.

5. The method of claim 1 wherein the period is up to one hour.

6. The method of claim 1 wherein the period is up to one day.

7. The method of claim 1 the period is more than one day.

8. The method of claim 1 wherein the frequency range is from about 5 kHz to about 15 kHz.

9. The method of claim 1 wherein the frequency range is from about 3 kHz to about 15 kHz.

10. The method of claim 1 wherein the frequency range is from about 3 kHz to about 20 kHz.

11. The method of claim 1 wherein the frequency range is from about 3 kHz to about 10 kHz.

12. The method of claim 1 wherein the electrical signal has a frequency of about 10 kHz.

13. The method of claim 1 wherein when applied, the electrical signal causes reduction or inhibition of patient pain.

14. A patient treatment device, comprising:

an implantable signal generator having a connector and being programmed to:

direct generate at least one non-paresthesia-producing electrical signal having a frequency in a frequency range of from about 1.5 kHz to about 50 kHz, and

on a repeated basis, automatically interrupt the electrical signal for a period of time, and

after completion of the period, automatically resume generating a non-paresthesia-producing electrical signal; and

at least one implantable signal delivery device having a proximal portion and a distal portion, the proximal portion coupleable to the connector of the implantable signal generator, the distal portion having multiple electrical contacts for delivering the electrical signal to one or more locations along a patient's spinal cord.

15. The patient treatment device of claim 14 wherein the period is up to 20 minutes.

16. The patient treatment device of claim 14 wherein the period is up to one hour.

17. The patient treatment device of claim 14 wherein the period is up to one day.

18. The patient treatment device of claim 14 wherein the period is up to ten minutes.

19. The patient treatment device of claim 14 wherein the patient treatment device is configured to deliver the electrical signal to reduce or inhibit pain in the patient.

20. The patient treatment device of claim 14 , further comprising an extension, and wherein the connector is directly connectable to the extension toward a first end of the extension, and the at least one implantable signal delivery device is directly connectable to the extension toward a second end of the extension.

21. A method for treating a patient, comprising:

programming a signal generator to deliver at least one non-paresthesia-producing electrical signal to the patient's spinal cord, via at least one implantable signal delivery device, the signal having a frequency in a frequency range of from about 3 kHz to about 20 kHz; and

programming the signal generator to repeatedly interrupt the signal delivery for periods of time.

22. The method of claim 21 wherein the signal generator is programmed to repeatedly interrupt the signal delivery on a cyclic basis.

23. The method of claim 21 wherein the signal generator is programmed to repeatedly interrupt the signal delivery automatically.

24. The method of claim 21 wherein the periods of time are up to 20 minutes.

25. The method of claim 21 wherein the periods of time are up to one hour.

26. The method of claim 21 wherein the periods of time are up to one day.

27. The method of claim 21 wherein the periods of time are more than one day.

28. The method of claim 21 wherein the frequency range is from about 5 kHz to about 15 kHz.

29. The method of claim 21 wherein the frequency range is from about 3 kHz to about 15 kHz.

30. The method of claim 21 wherein the frequency range is from about 3 kHz to about 10 kHz.

31. The method of claim 21 wherein at least a portion of the electrical signal has a frequency of about 10 kHz.

32. The method of claim 21 wherein when applied, the electrical signal causes reduction or inhibition of patient pain.

33. A spinal cord stimulation system, comprising:

a signal generator programmed to:

generate at least one non-paresthesia-producing electrical signal having a frequency in a frequency range of from about 1.5 kHz to about 50 kHz,

automatically interrupt the electrical signal for a period of time, and

after completion of the period, automatically resume generating at least one non-paresthesia-producing electrical signal having a frequency in a frequency range of from about 1.5 kHz to about 50 kHz; and

at least one implantable signal delivery device electrically coupled to the signal generator and configured to deliver the electrical signal to one or more locations along a patient's spinal cord.

34. The system of claim 33 , wherein the period is up to 20 minutes.

35. The system of claim 33 , wherein the period is up to one hour.

36. The system of claim 33 , wherein the period is up to one day.

37. The system of claim 33 , wherein the period is more than one day.

38. The system of claim 33 , wherein the frequency range is from about 3 kHz to about 15 kHz.

39. The system of claim 33 , wherein the frequency range is from about 3 kHz to about 20 kHz.

40. The system of claim 33 , wherein the frequency range is from about 3 kHz to about 10 kHz.

Assignments (7)
RELEASE OF SECURITY INTEREST Recorded Apr 4, 2025
From: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
To: NEVRO CORP.
Reel/Frame 070743/0001 →
PATENT SECURITY AGREEMENT Recorded Dec 1, 2023
From: NEVRO CORP.
To: WILMINGTON TRUST, NATIONAL ASSOCIATION, AS AGENT
Reel/Frame 065744/0302 →
CORRECTIVE ASSIGNMENT TO CORRECT THE RECEIVING PARTY DATA NAME PREVIOUSLY RECORDED AT REEL: 030714 FRAME: 0925. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT . Recorded Nov 21, 2016
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORP.
Reel/Frame 040656/0316 →
RELEASE OF SECURITY INTEREST Recorded Jun 27, 2016
From: CRG SERVICING LLC
To: NEVRO CORP.
Reel/Frame 039168/0890 →
ASSIGNMENT AGREEMENT (REAFFIRMATION) Recorded Jun 13, 2016
From: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
To: CRG SERVICING LLC,
Reel/Frame 038984/0865 →
SECURITY INTEREST Recorded Dec 12, 2014
From: NEVRO CORP.
To: CAPITAL ROYALTY PARTNERS II L.P.; CAPITAL ROYALTY PARTNERS II - PARALLEL FUND "A" L.P.; PARALLEL INVESTMENT OPPORTUNITIES PARTNERS II L.P.
Reel/Frame 034619/0546 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 28, 2013
From: ALATARIS, KONSTANTINOS; WALKER, ANDRE B.; PARKER, JON; CHITRE, YOUGANDH; PARK, SANGSOO WESLEY; THACKER, JAMES R.
To: NEVRO CORPORATION
Reel/Frame 030714/0925 →